22 Mar 2022

Participants sought: People with COPD for in-home nasal high flow air therapy

Participants with COPD sought for 8 day in-home study
EAGLE is a phase II trial to assess feasibility of using nasal high flow for breathlessness in participants with chronic obstructive pulmonary disease (COPD) who do not qualify for domiciliary long-term oxygen therapy.

We are seeking participants for our 8-day trial of in-home nasal high flow air therapy for COPD patients who experience breathlessness. The study aims to determine the effects of in-home nasal high flow air therapy on breathlessness, quality of life, and other symptom management. 

Contact Dr Amy Pascoe:

No comments:

Post a Comment

Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.

Related Posts Plugin for WordPress, Blogger...